GB9109887D0 - Pharmaceutical formulations for the treatment of peripheral vascular diseases - Google Patents

Pharmaceutical formulations for the treatment of peripheral vascular diseases

Info

Publication number
GB9109887D0
GB9109887D0 GB919109887A GB9109887A GB9109887D0 GB 9109887 D0 GB9109887 D0 GB 9109887D0 GB 919109887 A GB919109887 A GB 919109887A GB 9109887 A GB9109887 A GB 9109887A GB 9109887 D0 GB9109887 D0 GB 9109887D0
Authority
GB
United Kingdom
Prior art keywords
treatment
pharmaceutical formulations
peripheral vascular
vascular diseases
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB919109887A
Other versions
GB2243779B (en
GB2243779A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IDB Holding SpA
Original Assignee
IDB Holding SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IDB Holding SpA filed Critical IDB Holding SpA
Publication of GB9109887D0 publication Critical patent/GB9109887D0/en
Publication of GB2243779A publication Critical patent/GB2243779A/en
Application granted granted Critical
Publication of GB2243779B publication Critical patent/GB2243779B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB9109887A 1990-05-09 1991-05-08 Pharmaceutical formulations containing vincamine for treatment of peripheral vascular diseases Expired - Fee Related GB2243779B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909010389A GB9010389D0 (en) 1990-05-09 1990-05-09 Pharmaceutical formulations for the treatment of peripheral vascular diseases

Publications (3)

Publication Number Publication Date
GB9109887D0 true GB9109887D0 (en) 1991-07-03
GB2243779A GB2243779A (en) 1991-11-13
GB2243779B GB2243779B (en) 1994-06-15

Family

ID=10675691

Family Applications (2)

Application Number Title Priority Date Filing Date
GB909010389A Pending GB9010389D0 (en) 1990-05-09 1990-05-09 Pharmaceutical formulations for the treatment of peripheral vascular diseases
GB9109887A Expired - Fee Related GB2243779B (en) 1990-05-09 1991-05-08 Pharmaceutical formulations containing vincamine for treatment of peripheral vascular diseases

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB909010389A Pending GB9010389D0 (en) 1990-05-09 1990-05-09 Pharmaceutical formulations for the treatment of peripheral vascular diseases

Country Status (5)

Country Link
CH (1) CH682454A5 (en)
FR (1) FR2661831B1 (en)
GB (2) GB9010389D0 (en)
HK (1) HK1004889A1 (en)
IT (1) IT1257884B (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2108993A1 (en) * 1970-10-28 1972-05-26 Forschag Vincamine alkaloid fraction - with sedative and vasoregulating effect
FR2255890B1 (en) * 1973-12-28 1978-01-13 Centre Etd Ind Pharma
FR2255885B1 (en) * 1973-12-28 1977-09-09 Centre Etd Ind Pharma
IL60613A (en) * 1979-08-16 1983-12-30 Richter Gedeon Vegyeszet Dermatological compositions applicable directly to the skin comprising an eburnamenine derivative and process for their preparation
US4511557A (en) * 1981-08-24 1985-04-16 Gauri Kailash Kumar Pharmaceutical composition
US4612194A (en) * 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
ATE82684T1 (en) * 1984-03-07 1992-12-15 Roshdy Ismail MEANS FOR TREATMENT AND PROTECTION OF THE SKIN.
EP0266968A3 (en) * 1986-11-03 1988-08-24 Gérard G. Cohen Gelled ointment of vasodilating agent

Also Published As

Publication number Publication date
ITMI911206A1 (en) 1992-11-03
IT1257884B (en) 1996-02-16
GB9010389D0 (en) 1990-06-27
GB2243779B (en) 1994-06-15
ITMI911206A0 (en) 1991-05-03
GB2243779A (en) 1991-11-13
FR2661831B1 (en) 1995-04-28
CH682454A5 (en) 1993-09-30
HK1004889A1 (en) 1998-12-11
FR2661831A1 (en) 1991-11-15

Similar Documents

Publication Publication Date Title
AU4048295A (en) Peptide medicaments for the treatment of disease
AP9000206A0 (en) Treatment of conditions & diseases
EP0243002A3 (en) Pharmaceutical composition for the treatment of periodontal diseases
DE69326539D1 (en) CYTOTOXIC MEDICINE THERAPY
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
GB9226832D0 (en) Pharmaceutical preparations for the treatment of psoriasis
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
AU9173191A (en) Medicaments for the treatment of papillomavirus diseases
EP0584034A3 (en) Cytotoxic drug conjugates for treatment of neoplastic diseases.
AP9100290A0 (en) Pharmaceutical treatment
EP0448004A3 (en) Catheter for medical treatment
ZA875847B (en) Pharmaceutical compositions for the treatment of occlusive vascular diseases
HUP9901247A3 (en) Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency
GB9103278D0 (en) Drug for the treatment of dermatitis
IL104132A0 (en) Compositions for the treatment of mammalian diseases
PT84755A (en) Process for the preparation of a pharmaceutical composition for the treatment of skin diseases
ZA914435B (en) Treatment of disease
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
EP0457671A3 (en) Dipyridamide for the treatment of diseases of the central or peripheral nervous system
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
GB9109887D0 (en) Pharmaceutical formulations for the treatment of peripheral vascular diseases
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
ZA944671B (en) Medicaments for the treatment of inflammatory diseases

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20030508